Skip to content
Wenlo
Sign in
← Markets

IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. (IDXX) — Form 144: Proposed sale of shares

144IDXXFiled Nov 4, 2026, 4:04 PM ET

AI-generated summary

MICHAEL J LANE, Officer of IDEXX Laboratories, Inc., proposed to sell 3,979 shares of Common stock with an aggregate market value of $2,740,107.92 through Morgan Stanley Smith Barney LLC Executive Financial Services. The approximate sale date is 2026-11-04. The shares to be sold were acquired through an employee stock purchase plan, restricted stock vesting, and stock options.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Seller
MICHAEL J LANE
Relationship
Officer
Shares to sell
3,979
Market value
$2,740,107.92
Approximate sale date
Nov 4, 2026
Broker
Morgan Stanley Smith Barney LLC Executive Financial Services
Acquired (1)
Dec 31, 2020 · Employee Stock Purchase Plan
Acquired (2)
Feb 14, 2022 · Restricted Stock
Acquired (3)
Nov 3, 2020 · Exercised Shares
Remarks
  1. The securities to be sold were acquired upon the exercise of Stock Options during the period of 11/03/2020 through 11/07/2023. The securities to be sold were acquired upon the purchase of Employee Stock Purchase Plan shares during the period of 12/31/2020 through 09/30/2025. The securities to be sold were acquired upon the vesting of restricted stock during the period of 02/14/2022 through 02/14/2026.

More IDXX filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.